{"id":"W3183300604","doi":"10.1016/s2213-8587(21)00180-7","title":"Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":245,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk; Bayer Fund; Novartis; Servier; Amgen; Pfizer; Bristol-Myers Squibb; AstraZeneca; Fundação Lemann; Boehringer Ingelheim","keywords":"Medicine; Dapagliflozin; Discontinuation; Placebo; Internal medicine; Adverse effect; Hazard ratio; Population; Kidney disease; Organ dysfunction; Randomized controlled trial; Clinical trial; Diabetes mellitus; Type 2 diabetes; Confidence interval; Sepsis; Endocrinology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005959693,0.0005881362,0.002490283,0.0004105406,0.0001979647,0.00007646558,0.0003484348,0.0001132995,0.0001931508],"category_scores_gemma":[0.0005021755,0.0003288072,0.0003013848,0.0007570311,0.0003135256,0.0001394775,0.000156094,0.0004896219,0.00002809404],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000240729,"about_ca_system_score_gemma":0.0003504092,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001759652,"about_ca_topic_score_gemma":0.000130227,"domain_scores_codex":[0.9957499,0.0005834461,0.000603693,0.0007764971,0.0005413181,0.001745142],"domain_scores_gemma":[0.9971622,0.0008027186,0.0003754515,0.001146221,0.0001442412,0.0003691598],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6154218,0.001370423,0.3766987,0.00006698819,0.003541767,0.0001768763,0.0003557319,0.000136324,0.00001735995,0.0002222805,0.000703974,0.001287814],"study_design_scores_gemma":[0.9634883,0.003208843,0.02007092,0.00003996411,0.003048022,0.000003108526,0.0003025318,0.0000275777,0.0004401785,0.00008389695,0.00889765,0.0003889704],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9865455,0.001108568,0.00002870348,0.002362067,0.0003698283,0.007658122,0.0001190744,0.0001914468,0.001616691],"genre_scores_gemma":[0.9942706,0.00028756,0.0001371641,0.001642606,0.0003614417,0.002163251,0.000572581,0.0000698439,0.0004949453],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3566278,"threshold_uncertainty_score":0.9999164,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03020509431940633,"score_gpt":0.3003468337290783,"score_spread":0.270141739409672,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}